A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose

Seminars in Nuclear Medicine

Volumn 19, Issue 1, 1989, Pages 33-46

  Losilevsky, Galina ^a,b,c,d   Israel, Ora ^a,b,c,d   Frenkel, Alex ^a,b,c,d   Even Sapir, Einat ^a,b,c,d   Ben Haim, Simona ^a,b,c,d   Front, Avi ^a,b,c,d   Kolodny, Gerald M ^a,b,c,d   Front, Dov ^a,b,c,d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

AUDIOVISUAL EQUIPMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; RADIATION DOSE; REVIEW; SCINTISCANNING; STANDARD; TISSUE DISTRIBUTION;

CONTRAST MEDIA; HUMAN; MODELS, STRUCTURAL; NEOPLASMS; RADIATION DOSAGE; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0024491844     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(89)80034-0     Document Type: Article

References (48)

1. In vivo quantitation using SPECT of radiopharmaceutical uptake by human meningiomas
2. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake
3. SPECT quantitation of Co-57 bleomycin delivery to human brain tumors
4. Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination,
5. Dose: A critical factor in cancer chemotherapy
6. Dose-response is alive and well
7. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer
8. Quantitative emission tomography
9. Determination of organ volume by single photon emission computed tomography
10. Letter to the editor
11. Requirements for a treatment planning system for radioimmunotherapy
12. A new threshold method for volume determination by SPECT
13. Quantitative organ visualization using SPECT
14. Improved SPECT using simultaneous emission and transmission tomography
15. Comparison of three boundary detection methods for SPECT using compton scattered photons
16. SPECT compton-scattering correction by analysis of energy spectra
17. Scientists advocate using empirical data from physiologic PET and SPECT images
18. Le bleomycine marquee au Do-57. Interet dans le diagnostique des tumeurs malignes et de leur extension
19. Clinical evaluation of tumor scanning with Co-57 bleomycin
20. Some experience with Co-57 as a tumor seeking agent
21. Clinical evaluation of radiolabeled bleomycin (bleo) for tumor detection
22. Dose evaluation of Co-55 bleomycin
23. Radiation absorbed doses from Co-57 and Co-55 bleomycin
24. Synthesis and distribution of a radiolabeled anti-tumor agent cis-diamminodichloroplatinum (II)
25. Correlation of physicochemical and biological properties with in vivo biodistribution data for platinum-195m labeled chloroammineplatinum (II) complexes
26. Preparation and metabolism of a cisplatin/serum protein complex
27. Co-57 bleomycin scintigraphy
28. The blood tissue barrier of human brain tumors: Correlation of scintigraphic and ultrastructural findings: Concise communication
29. Microscale synthesis and biodistribution of Pt-195m-labeled cis-dichlorodiammineplatinum (II), cis-DDP radiopharmaceuticals II.
30. Clinical pharmacokinetics and drug monitoring
31. Pharmacokinetics of antineoplastic agents at the cellular level
32. Clinical implication of tumor cell heterogeneity
33. Criteria associated with destruction of leukemia and solid tumor cells in animals
34. Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs
35. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells
36. Variable bioavailability of oral mercaptopurine
37. Mechanism of resistance to daunorubicin in Ehrlich ascites tumor cells
38. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines
39. Genetic and biochemical characterization and multidrug resistance
40. New aspects of clinical drug resistance: The role of gene amplification and the reversal of resistance in drug refractory cancer
41. Radioactive agents for imaging
42. A schema for absorbed dose calculations for biologically distributed radionuclides. MIRD pamphlet no. 1
43. Estimates of absorbed fractions from monoenergetic photon sources uniformly distributed in various organs of heterogenous phantom. MIRD pamphlet no. 5
44. Absorbed fractions for photon dosimetry. MIRD pamphlet no. 3
45. A comparison of Tc-99m labeled human serum albumin and in vitro labeled red blood cells for blood pool studies
46. Dosimetry of Tc-99m labeled red blood scanning agents
47. Splenic sequestration of Tc-labeled heat treated RBC